real world setting
Showing 26 - 50 of >10,000
Tofacitinib After Use Of Rituximab In Rheumatoid Arthritis In A
Not yet recruiting
- Arthritis, Rheumatoid
-
Casablanca, MoroccoPfizer
Aug 2, 2022
Diroximel Fumarate Real-world Experience in Canada and Israel
Recruiting
- Relapsing Forms of MS
- Diroximel Fumarate
-
Haifa, Israel
- +5 more
Jan 31, 2023
Vertigo Trial in Washington (Otoband, Sham A, Sham B)
Active, not recruiting
- Vertigo
- Otoband
- +2 more
-
Washington, District of ColumbiaOtolith Labs
Mar 28, 2022
A Multi-Centre, Single-arm, Observational Study of EVUSHELD in
Active, not recruiting
- COVID-19
-
Qionghai, Hainan, China(2) Ruijin-Hainan Hospital Shanghai Jiaotong University School o
Jun 21, 2023
Learn About Use and Effects of CDK4/6 Inhibitors in Canadian
Active, not recruiting
- Breast Cancer
-
Kirkland, Quebec, CanadaPfizer Canada
Mar 5, 2023
Pathways of Asthma Patients Treated WithExtrafine ICS/LABA/LAMA
Recruiting
- Asthma
- Non-interventional
-
Durham, County Durham, United KingdomThe Haven Surgery, The Haven, Burnhope,
Jul 20, 2022
Vertigoheel® on Patients Suffering From Bilateral Vestibulopathy
Completed
- Vertigo
- +2 more
-
Munich, Bavaria, GermanyDepartment of Neurology, Ludwig Maximilian University
Jun 1, 2023
Endoscopic Retrograde Cholangiopancreatography (ERCP) Trial in United States (aScope™ Duodeno endoscope and aBox™ Duodeno)
Completed
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- aScope™ Duodeno endoscope and aBox™ Duodeno
-
Birmingham, Alabama
- +8 more
Jul 28, 2022
Hypertension, Diabete Mellitus Trial (O2O digital healthcare service)
Not yet recruiting
- Hypertension
- Diabete Mellitus
- O2O digital healthcare service
- (no location specified)
Nov 28, 2023
Treatments and Outcomes in Real-World Setting
Recruiting
- Headache Disorders, Secondary
- +6 more
- Clinical evaluation
-
Valladolid, SpainHospital Clínico Universitario de Valladolid
Aug 12, 2022
A NIS of Alpelisib in Combination With Fulvestrant in
Not yet recruiting
- Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
- Alpelisib
- Fulvestrant
- (no location specified)
Aug 9, 2022
Retrospective Data of Glucagon-like Peptide-1 Participanta With
Recruiting
- Diabetes Mellitus, Type 2
-
Skopje, North MacedoniaNovo Nordisk Investigational Site
Jul 22, 2022
Learn More About Iberogast Advance in the Real-world Setting
Recruiting
- Functional Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia
- +2 more
- Iberogast (STW5-II, BAY98-7410)
-
Multiple Locations, Many Locations, GermanyMany Locations
Jan 16, 2023
Analyze Prescription Pattern of Sugammadex and Its Effectiveness
Not yet recruiting
- Postoperative Complications
- +2 more
-
Seoul, Seongbuk-gu, Korea, Republic ofKorea University Anam Hospital
Mar 27, 2023
The DefiPace Study
Not yet recruiting
- Post-operative Atrial Fibrillation POAF
- (no location specified)
Oct 5, 2022
Nivolumab Plus Ipilimumab in Renal Cell Cancer in Real World
Active, not recruiting
- Advanced or Metastatic Renal Cell Carcinoma
-
Tokyo, JapanLocal Institution - 0001
May 25, 2022
(Called RETAF-PS) UsingPatient Survey to Learn More About
Not yet recruiting
- Prevention of Thromboembolic Events
- Atrial Fibrillation
-
Whippany, New JerseyBayer
Jul 21, 2022
TNFi as Monotherapy or Combination Therapy With MTX and Compare
Completed
- Rheumatoid Arthritis
- patterns of use of combination therapy and monotherapy
-
New York, New YorkPfizer
Oct 7, 2022
Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial
Completed
- Diabetic Macular Edema
-
Seoul, Korea, Republic ofNovartis Investigative Site
Apr 4, 2023
PRostate Olaparib Real World Evidence Study
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- (no location specified)
Sep 4, 2023
Ustekinumab in Participants Suffering From Inflammatory Bowel
Recruiting
- Crohn Disease
- Colitis, Ulcerative
-
Vandoeuvre les Nancy, FranceCHU de Nancy - Hôpital de Brabois
Aug 17, 2022
Humacyte's HAV for Arterial Replacement or Reconstruction in
Not yet recruiting
- Trauma
- +3 more
- HAV implantation
- (no location specified)
May 23, 2023
Omalizumab in Children With Allergic Asthma.
Completed
- Allergic Asthma
-
East Hanover, New JerseyNovartis Investigative Site
Jun 29, 2022
Study of Diroximel Fumarate in the Real-World Setting
Recruiting
- Relapsing Forms of MS
- Diroximel Fumarate
-
Washington, District of Columbia
- +11 more
May 9, 2022